Screener
Orchestra BioMed Holdings, Inc. OBIO Q3 2025 earnings
Reported November 10, 2025 · Before market open
Revenue$861.0KBeat by $119.6K
EPS-$0.40Miss by $0.02
Revenue estimate$741.4K
EPS estimate-$0.38
Next report
Nov 9, 2026 (in 2 months)Revenue estimate$128.0K
EPS estimate-$0.40
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Orchestra BioMed Holdings, Inc. report Q3 2025 earnings?
- Orchestra BioMed Holdings, Inc. (OBIO) reported Q3 2025 earnings on November 10, 2025 before market open.
- What were Orchestra BioMed Holdings, Inc.'s Q3 2025 revenue and EPS?
- Orchestra BioMed Holdings, Inc. reported revenue of $861.0K and eps of $-0.40 for Q3 2025.
- Did Orchestra BioMed Holdings, Inc. beat estimates in Q3 2025?
- Revenue beat the consensus estimate of $741.4K by $119.6K. EPS missed the consensus estimate of $-0.38 by $0.02.
- How did Orchestra BioMed Holdings, Inc.'s Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 12.8% from $987.0K a year earlier and eps grew 2.4% from $-0.41.
- Where can I find Orchestra BioMed Holdings, Inc.'s Q3 2025 SEC filings?
- You can read the 10-Q periodic report (0001104659-25-109128) directly on SEC EDGAR. The filing index links above go to sec.gov.
